Oncobell is a joint research program focused on molecular mechanisms and experimental therapies in cancer. It is a new program within the IDIBELL with the aim to fight cancer in a collective and multidisciplinary way. It includes an array of groups that cover the stages from basic frontier research all the way to clinical treatments of the patients.
The common nominator of the program is that all groups work on improving patients’ outcomes through either a molecular/pathway oriented approach or through a disease and clinical needs oriented approach. We believe that increasing the communication between groups linking these two approaches will lead to better ideas and shortcuts in the transition between lab results into the clinics.
2nd International Symposium: “Building bridges between science, cancer medicine and persons”
The second Oncobell symposium will be a forum to discuss basic and clinical advances in cancer research with outstanding professionals.
Isabel Fabregat
TGF-Beta and Cancer Group, Oncobell Program, IDIBELL – UB – CIBERehd, Barcelona
Ferran Guedea
Radiobiology & Cancer Group, Oncobell Program, IDIBELL – ICO, Barcelona
Purificación Muñoz
Ageing and Cancer Group, Oncobell Program, IDIBELL, Barcelona
Cristina Muñoz-Pinedo
Cell Death Regulation Group, Oncobell Program, IDIBELL – UB, Barcelona
Josep Mª Piulats
Clinical Research in Solid Tumors (CREST) Group, Oncobell Program, IDIBELL – ICO, Barcelona
Jordi Ponce
Gynecologic Cancer Group, Oncobell Program, IDIBELL – HUB, Barcelona
Javier Márquez
Administrative Support, Oncobell Program, IDIBELL, Barcelona
Antonio Gentilella
Metabolism and Cancer Group, Oncobell Program, IDIBELL – UB, Barcelona
Óscar Martínez-Tirado
Sarcoma Research Group, Oncobell Program, IDIBELL, Barcelona
Ernest Nadal
Preclinical and Experimental Research in Thoracic Tumors Group, Oncobell Program, IDIBELL – ICO, Barcelona
Cristina Santos
Colorectal Cancer Group, Oncobell Program, IDIBELL – ICO, Barcelona
